DS-1150

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDS-1150
Drug Alias NameDS-1150bDS-1150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose transporter type 4 stimulants
TargetsGlucose transporter type 4
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A